Datum Källa Rubrik Typ Alternativ
2023-07-24 Ziccum Ziccum säkrar andra Feasibility-avtalet på två månader: VD-intervju på svenska Pressreleaser Ladda ner | Visa Stäng
2023-07-20 Ziccum Ziccums Q2-rapport - VD-uppdatering på svenska Pressreleaser Ladda ner | Visa Stäng
2023-07-18 Ziccum ZICCUM AB (publ) Interim report Q2 2023 Rapporter Ladda ner | Visa Stäng
2023-07-17 Ziccum Ziccum signs Evaluation Agreement for Feasibility Study with major global Pharmaceutical Corporation Pressreleaser Ladda ner | Visa Stäng
2023-06-19 Ziccum Ziccum sponsors the Global mRNA-Based Therapeutics Summit, Boston MA, July 26-28 Pressreleaser Ladda ner | Visa Stäng
2023-06-05 Ziccum Ziccum joint proposal not selected for detailed application in current CEPI Call Pressreleaser Ladda ner | Visa Stäng
2023-06-02 Ziccum Ziccum appoints senior biopharma executive as new CFO Pressreleaser Ladda ner | Visa Stäng
2023-05-30 Ziccum Ziccum AB: BioStock Life Science Spring Summit med Ziccum Pressreleaser Visa Stäng
2023-05-30 Ziccum Ziccum AB: BioStock Life Science Spring Summit with Ziccum Pressreleaser Visa Stäng
2023-05-26 Ziccum Aerosol and inhalation authority Per Gerde joins Board of Directors of Ziccum AB Pressreleaser Ladda ner | Visa Stäng
2023-05-25 Ziccum Ziccum CEO to present at BioStock Life Science Spring Summit Pressreleaser Ladda ner | Visa Stäng
2023-05-24 Ziccum Kommuniké från årsstämma i Ziccum AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-24 Ziccum Bulletin from the Annual General Meeting of Ziccum AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-11 Ziccum Strategin ger resultat med betald studie i samarbete med toppbolag: VD-intervju på svenska Pressreleaser Ladda ner | Visa Stäng
2023-05-09 Ziccum Ziccum signs Evaluation Agreement with Biopharmaceutical Corporation focused on mRNA technologies Pressreleaser Ladda ner | Visa Stäng
2023-05-09 Ziccum Ziccums Q1-resultat: VD-uppdatering på svenska Pressreleaser Ladda ner | Visa Stäng
2023-05-08 Ziccum KOMPLETTERING TILL KALLELSEN TILL ÅRSSTÄMMA I ZICCUM AB (PUBL), ATT HÅLLAS DEN 24 MAJ 2023, KL. 11.00 I BOLAGETS LOKALER PÅ SCHEELEVÄGEN 22 I LUND Pressreleaser Ladda ner | Visa Stäng
2023-05-02 Ziccum Ziccum AB filing three patent applications as part of new, expanded strategy to strengthen patent protection Pressreleaser Ladda ner | Visa Stäng
2023-04-26 Ziccum ZICCUM AB (publ) releases Interim report Q1 2023 Rapporter Ladda ner | Visa Stäng
2023-04-24 Ziccum KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-03-20 Ziccum Ziccum reports positive results from drying of active mRNA and promising mRNA activity after powder reconstitution Pressreleaser Ladda ner | Visa Stäng
2023-03-17 Ziccum Ziccum to attend BIO-Europe Spring in Basel Pressreleaser Ladda ner | Visa Stäng
2023-03-10 Ziccum Ziccum AB joins innovative financial platform for Investor Relations management and European outreach Pressreleaser Ladda ner | Visa Stäng
2023-02-17 Ziccum ZICCUM AB (publ) releases Annual Report 2022 Rapporter Ladda ner | Visa Stäng
2023-01-27 Ziccum ZICCUM AB (publ) Year-end report Q4 2022 Analyser Ladda ner | Visa Stäng
2023-01-23 Ziccum Ziccum submits Expression of Interest for CEPI funding Analyser Ladda ner | Visa Stäng
2023-01-18 Ziccum Ziccum CEO to present at international mRNA Summit in Berlin Analyser Ladda ner | Visa Stäng
2022-12-16 Ziccum Ziccum awarded 10 MSEK Eurostars funding for 3D-modeling and Digital twin project Analyser Ladda ner | Visa Stäng
2022-12-14 Ziccum Ziccum launches new, expanded website Analyser Ladda ner | Visa Stäng
2022-12-08 Ziccum Ziccum signs agreement with Zurich University of Applied Sciences on advanced 3D-modeling project Analyser Ladda ner | Visa Stäng
2022-10-28 Ziccum Ziccums Q3-resultat: VD-uppdatering på svenska Analyser Ladda ner | Visa Stäng
2022-10-27 Ziccum ZICCUM AB (publ) Interim report Q3 2022 Analyser Ladda ner | Visa Stäng
2022-10-24 Ziccum Ziccum generates proof of successful drying of lipid nanoparticles in mRNA project Analyser Ladda ner | Visa Stäng
2022-09-27 Ziccum Ziccum reopens application for CEPI funding on thermostable vaccines with new partner Analyser Ladda ner | Visa Stäng
2022-09-23 Ziccum Ziccum receives results from evaluation study with leading Pharmaceutical Corporation Analyser Ladda ner | Visa Stäng
2022-09-14 Ziccum Ziccum and Zurich University of Applied Sciences submit joint application for Eurostars funding Analyser Ladda ner | Visa Stäng
2022-09-01 Ziccum Ziccum on the move: company to attend major industry events across Europe in 2022 Analyser Ladda ner | Visa Stäng
Analyser | 1 Sep 2022 | Ziccum

Ziccum on the move: company to attend major industry events across Europe in 2022

Ziccum AB will be intensifying its partnering and networking dialogues at a series of leading pharma industry events throughout Europe this year. CEO Ann Gidner: “As we strengthen our connections with colleagues throughout the industry, we remain confident in the unique advantages that ambient drying and thermostable vaccines represent. It’s going to be an exciting season.”

CEO Ann Gidner and Chairman Fredrik Sjövall will attend Nordic Life Sciences Days in Malmö, 28 – 29 September, and Bio-Europe, the largest industry event for biopharma professionals in Europe, in Leipzig on 23 – 26 October.

The company’s CEO together with Scientific Director Fabrice Rose will attend the New Updates in Drug Formulation & Bioavailability conference in Copenhagen on September 6, and the 23rd World Vaccine Congress Europe conference in Barcelona October 11 – 14.

Ziccum CEO Ann Gidner: “Since my appointment in May we have constantly emphasized our commitment to building new strategic dialogues and relationships within the industry. Our unique ambient drying technology for vaccines and biologics is an enormously valuable technology. Together with our Chairman and Scientific Director I look forward to sharing our science and offering at these important industry events.”

BOOK A MEETING ahead of the events with CEO Ann Gidner, Chairman Fredrik Sjövall or Scientific Director Fabrice Rose here:

Ann Gidner CEO – Mobile: +46 722 140 141
e-mail:  gidner@ziccum.com

Fredrik Sjövall, Chairman – Mobile: +46 706 45 0875
e-mail:  sjovall@ziccum.com

Fabrice Rose, Scientific Director: +46 709 802 520
e-mail: rose@ziccum.com

2022-08-23 Ziccum ZICCUM AB (publ) Interim report Q2 2022 Analyser Ladda ner | Visa Stäng

Kommande händelser

29 Apr 2024 | Kvartalsrapport 2024-Q1
17 May 2024 | Årligutdelning
30 Jul 2024 | Kvartalsrapport 2024-Q2
29 Oct 2024 | Kvartalsrapport 2024-Q3
29 Jan 2025 | Bokslutskommuniké 2024